BIOS · BioSenic · Financials
Market Cap
1.31M EUR
Shares
652.86M
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Browse captured authority reports and their original financial labels
Revenue
3.07M
+464.8%
FY2024
Net Income
-4.77M
+83.4%
FY2024
Operating Margin
-169.71%
+1126.8pp
FY2024
Operating Cash Flow
-2.22M
+36%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| EUR | 3.07M | 543K | 0 | 0 | 1M |
| EUR | 2.31M | 3.93M | 1.03M | 619K | 15.42M |
| EUR | 2.77M | 3.65M | 1.55M | 570K | 3.27M |
| EUR | -5.21M | -7.04M | -2.32M | -877K | -15.02M |
| EUR | 2.23M | 5.95M | 741K | 107K | 747K |
| EUR | -6.71M | -29.03M | -3.05M | -984K | -15.75M |
| EUR | 0 | -7000 | 0 | 0 | 78K |
| EUR | -4.77M | -28.78M | -2.04M | -984K | -11.94M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.